Loading...

'2/10/2026 10:17:02 AM'

Prescribing Isotretinoin: FDA Approves iPLEDGE Modifications

Modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy aim to reduce challenges for patients, prescribers and pharmacies. Medscape Medical News

'2/10/2026 9:47:04 AM'

4 Questions Rival Lipid Panel for Assessing Men’s Heart Risk

Men in their thirties and forties often overlook key clues that could help them slow the progression of cardiovascular disease. Medscape Medical News

'2/10/2026 9:12:34 AM'

Comparing Paracetamol and Ibuprofen Safety in Infant Care

Paracetamol and ibuprofen show no significant difference in the risk for eczema or bronchiolitis during the first year of life in infants, and may be considered safe for managing fever or pain. Medscape Medical News

'2/10/2026 9:08:17 AM'

Metabolic Syndrome Tied to Glaucoma Risk

Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening. Medscape Medical News

'2/10/2026 8:04:20 AM'

NHS Backs New A&E Care Areas for Patients Facing Long Waits

NHS England has proposed new care areas within A&E for longer waits, but emergency clinicians warn bed shortages will still drive delays. Medscape News UK

'2/10/2026 4:44:27 AM'

Medscape Poll Finds Wide Opposition to Federal Vax Recs

Most clinicians said they would stick with guidance from major medical groups, such as the American Academy of Pediatrics. Medscape Medical News

'2/10/2026 3:58:55 AM'

Which Comes First, EBV or MS? The Answer May Be Complicated

Investigators have identified patients who tested positive for the Epstein-Barr Virus 9 years after they were diagnosed with MS, challenging the prevailing notion that the virus precedes MS. Medscape Medical News

'2/10/2026 3:12:03 AM'

Vitamin K Antagonists May Not Worsen COPD Outcomes

In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization for acute exacerbation of COPD and death than direct oral anticoagulants. Medscape Medical News

'2/10/2026 2:37:37 AM'

New Hope for Factor VIIa in Intracerebral Hemorrhage

New analyses indicate factor VIIa could benefit a small group of patients with intracerebral hemorrhage treated very early, reframing a therapy once thought unlikely to work. Medscape Medical News

'2/10/2026 2:31:31 AM'

Alzheimer Antibody Therapy Denied Approval in Scotland

The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence. Medscape News UK

'2/10/2026 2:24:10 AM'

Potential Noninvasive Alternative to Right Heart Cath in HF

T2 mapping can match right heart catheterization for measuring the severity of heart failure. Medscape Medical News

'2/10/2026 2:16:12 AM'

Sublingual Therapy Effective in Seasonal Asthma and Rhinitis

Sublingual immunotherapy for grass and dust mites reduces the proportions of patients experiencing asthma exacerbations and frequently using reliever medication in allergic asthma and rhinitis. Medscape Medical News

'2/10/2026 2:11:56 AM'

First-In-Class Neuroprotective Drug Improves Stroke Outcomes

A neuroprotective agent improved 90-day functional outcomes and reduced poststroke depression and anxiety in patients with ischemic stroke. Medscape Medical News

'2/10/2026 2:11:53 AM'

Rehab Therapy Beneficial in Children With Perinatal Stroke

A high-dose rehabilitation therapy improves motor outcomes in infants with perinatal stroke, offering rare evidence to guide early intervention during a critical window of brain development. Medscape Medical News

'2/10/2026 2:03:19 AM'

Coffee, Tea May Protect Against Dementia but Hold the Decaf

A decades-long cohort study shows drinking caffeinated coffee and tea in moderation is linked to lower dementia risk and improved cognitive function. Medscape Medical News

'2/10/2026 2:02:45 AM'

The Rise of Nutritional Psychiatry in Europe

As evidence grows, clinicians debate whether diet belongs in specialist clinics or everyday practice — and how nutrition should sit alongside drugs and therapy. Medscape News Europe

'2/10/2026 2:01:21 AM'

Kailera, Hengrui's Experimental Pill Shows 12.1% Weight Loss in Mid-stage Trial

U.S.-based Kailera Therapeutics and its partner Jiangsu Hengrui Pharmaceuticals said on Tuesday their experimental oral obesity drug helped patients ‌lose up to 12.1% body... Reuters Health Information

'2/10/2026 2:00:00 AM'

Somapacitan Effective in Small-for-Gestational-Age Children

Once-weekly somapacitan is effective and safe over the long term in prepubertal children born small for gestational age with short stature, including those switching from daily growth hormone therapy. Medscape News UK

'2/10/2026 2:00:00 AM'

Outcomes After Early Pregnancy Membrane Rupture

Early membrane rupture before 24 weeks of gestation can still result in live birth, and most infants survive to discharge without major complications. Medscape News UK

'2/10/2026 2:00:00 AM'

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows. Medscape News UK